A new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging lays the foundation for treating addiction with transcranial magnetic stimulation
In a study investigating the use of transcranial magnetic stimulation (TMS) for drug addiction, researchers at Medical University of South Carolina are the first to demonstrate that the noninvasive brain stimulation technique can dampen brain activity in response to drug cues in chronic alcohol users and chronic cocaine users. The findings are published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Although the last 50 years of clinical and preclinical research have demonstrated that addiction is a brain disease, there are still no neural circuit-based treatments for substance dependence or the brain functions involved in the disorder. “Here, for the first time, we demonstrate that a new non-invasive brain stimulation technique may be the first tool available to fill this critical void in addiction treatment development,” said senior author Colleen Hanlon, PhD.
Elevated brain activity in response to drug cues—referred to as cue reactivity—occurs with many types of drugs, including nicotine, alcohol, marijuana, and cocaine. Cue reactivity also predicts relapse in addiction, so treatment approaches targeting the neural circuitry related to cue reactivity may directly impact cue-induced relapse in patients.
“Therefore, these results have a tremendous potential to impact both basic discovery neuroscience as well as targeted clinical treatment development for substance dependence,” said Dr. Hanlon.
First author of the paper Tonisha Kearney-Ramos, PhD, and colleagues performed two independent studies at the same time, one involving 25 people with cocaine use disorder and the other involving 24 people with alcohol use disorder. The participants received one session of TMS, which targeted magnetic stimulation to circuitry critical for drug-taking behaviors—the ventromedial prefrontal cortex. The real stimulation session was compared against a sham session that mimicked the experience of receiving TMS without actual brain stimulation.
Brain imaging before and after TMS revealed that when alcohol users viewed images of alcohol-related cues, such as a liquor bottle, the single TMS session significantly reduced their drug cue reactivity. The same was true for cocaine users when viewing images of cocaine-related cues.
“Since cue reactivity has previously been associated with abstinence, these studies suggest a common mechanism for treatment effects across disorders, with fMRI serving as a promising neural readout of treatment effects,” said Cameron Carter, MD, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
However, it is still unclear if the changes in brain activity observed in the study will translate to reduced drug or alcohol use. The participants did not report any changes in their drug or alcohol craving after TMS. The authors think that repeated sessions of the targeted stimulation may be needed to see changes in self-reported craving. The researchers hope to answer this question in an ongoing clinical trial involving multiple TMS sessions in cocaine users.
In addition to substance abuse, elevated cue-reactivity is a core symptom of many diseases, such as post-traumatic stress disorder, generalized anxiety disorder, traumatic brain injury, smoking, and obesity, said Dr. Hanlon. “Therefore, the treatment described in this manuscript may have implications far beyond the substance abuse field.”
The Latest on: Transcranial magnetic stimulation
via Google News
The Latest on: Transcranial magnetic stimulation
- Mental Health Monday: What is Transcranial Magnetic Stimulation (TMS) treatment, and is it right for you?on August 1, 2022 at 3:12 pm
Mental Health Monday, the new weekly segment on KOVE 1330 AM / 107.7 FM’s Coffee Time, hosted by Vince Tropea, continued today with guest Dr. David Martorano, MD, Assistant Medical Director, Director ...
- Repetitive Transcranial Magnetic Stimulation as an Augmentative Strategy for Treatment-resistant Depressionon July 29, 2022 at 5:00 pm
We identified articles for inclusion in this meta-analysis by: Searching MEDLINE and Cochrane Central Register of Controlled Trials (CENTRAL) from 1 January 1995 to 30 November 2013, using the key ...
- Transcranial magnetic stimulation for treatment-resistant depressionon July 28, 2022 at 2:32 pm
Major depressive disorder is a mood disorder that lasts two weeks or longer and interferes with daily life. One in three adults with depression aren’t helped by talk therapy or medication. For those ...
- The Brain Lab Delivers the Future of Brain Healthon July 27, 2022 at 4:04 pm
At The Brain Lab, every patient receives life-changing outpatient care that would have been impossible even a few years ago,” said Nicholas Mathews, co-founder of The Brain Lab. Relying on the latest ...
- TMS helps some patients with anxiety and depressionon July 26, 2022 at 3:27 pm
DENVER (KDVR) — Transcranial magnetic stimulation, or TMS, is becoming a more common way to treat symptoms of anxiety and depression. TMS is a non-invasive form of deep brain stimulation in ...
- Global TMS(Transcranial Magnetic Stimulation) Coil Market 2022 Top Manufacturers, Key Trends, Progression Status and Business Trends to 2028on July 25, 2022 at 10:59 pm
Coil Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 presented by MarketsandResearch.biz enables the end-users to make profitable business-related decisions that will ...
- Why Brain Stimulation Shouldn't Be Overlooked as a Treatment for Depressionon July 22, 2022 at 1:58 am
In the USA, repetitive transcranial magnetic stimulation (rTMS) was cleared by the Food and Drug Administration (FDA) in 2008 to treat patients suffering from treatment resistant depression, or in ...
- Robot for Transcranial Magnetic Stimulation (TMS)on July 21, 2022 at 5:00 pm
Duke University’s Department of Psychiatry and Behavioral Sciences employs a coil positioning robot for Transcranial Magnetic Stimulation (TMS) at their Brain Stimulation Center. The SmartMove ...
- FDA approves transcranial magnetic stimulation system for patients with anxious depressionon July 21, 2022 at 7:25 am
The FDA has approved Neuronetics’ NeuroStar Advanced Therapy for Mental Health, a transcranial magnetic stimulation system for treatment of anxiety symptoms in adults with major depressive ...
via Bing News